Nicholas Nelson joined Caris in June 2018 and currently serves as Senior Vice President and Chief Business Officer, responsible for corporate and business development.
Prior to Caris, he was Vice President of Commercial and Corporate Development at Trovagene, where he led business and market development for the company’s oncology based non-invasive biopsy portfolio. Before Trovagene, Mr. Nelson spent 10 years at Illumina in R&D, technical service, sales and leadership positions in the New and Emerging Markets business unit focused on clinical and consumer markets. He has contributed to the design and creation of over a dozen genetic analysis systems and tests, and has established partnerships and collaborations enabling high growth genomics businesses throughout his career.
Mr. Nelson received his Bachelor of Science degree in Cellular and Molecular Biology from San Diego State University.